This top stock gives you three ways to gain

Article Excerpt

Swiss pharmaceutical giant Novartis spun off Alcon just last year. And as we’ve said many times before, spinoffs are the closest thing you can find to a sure thing, regardless of market ups and downs. Alcon also gives you two other exciting ways to profit. First, it offers you exposure to rapidly expanding, worldwide demand for its contact lenses and cataract surgery products; and, two, its global operations and technological leadership enhance the possibility of it attracting a lucrative takeover bid from a rival or a global health-care giant. We believe trends now underway—including Alcon’s strong position in its key markets—have set its sales, profit and share price on a strong growth path. We continue to recommend this stock as a Power Buy. ALCON $61.46 (New York symbol ALC; TSINetwork Rating: Extra Risk) (www.alcon.com; Shares o/s: 491.7 million; Market cap: $29.2 billion; No dividends) is the world’s biggest eye-care company. Specifically, it’s the leader in ocular surgical supplies and No. 2 in contact lenses. While Alcon is based…